Search results
Objective: The aim of this study was to assess long-term effects for women following the use of magnesium sulphate for pre-eclampsia. Design: Assessment at 2-3 years after delivery for women recruited to the Magpie Trial (recruitment in 1998-2001, ISRCTN 86938761), which compared magnesium sulphate with placebo for pre-eclampsia.
28 Ogo 2008 · In this multicenter, placebo-controlled, double-blind trial, we randomly assigned women at imminent risk for delivery between 24 and 31 weeks of gestation to receive magnesium sulfate,...
1 Mac 2007 · Between 1998 and 2001, 10 141 women were recruited to the Magpie Trial at 175 hospitals in 33 countries. 8 The women were eligible for the trial if they had pre-eclampsia (blood pressure ≥140/90 mmHg and 1+ proteinuria) during pregnancy, if in labour or up to 24 hours postpartum and if there was uncertainty about whether to use magnesium ...
26 Okt 2002 · The results of the Magpie Trial (June 1, p 1877) confirm claims that magnesium sulphate given during labour and for at least 24 h post partum will reduce the risk of seizures in women with severe pre-eclampsia or imminent eclampsia.
1 Jun 2002 · The Magpie Trial (MAGnesium sulphate for Prevention of Eclampsia) was a large international trial designed to evaluate the effects of magnesium sulphate on women and their babies.
Skip to Article Information. Objective The aim of this study was to assess long-term effects for women following the use of magnesium sulphate for pre-eclampsia. Design Assessment at 2–3 years after delivery for women recrui...
4 Okt 2006 · The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. Magpie Trial Follow-Up Study Collaborative Group. Correspondence: Dr L Duley, Magpie Trial Office, Nuffield Department of Medicine, Level 5, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK.
26 Okt 2002 · Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.
International Journal of Gynecology & Obstetrics. Volume 70, Issue S2 p. B47-B47. Free communication. The magpie trial: Magnesium sulphate versus placebo for women with pre-eclampsia. L. Bricker, First published: 10 December 2003. https://doi.org/10.1016/S0020-7292 (00)86253-0. Citations: 1.
1 Jun 2002 · Women allocated magnesium sulphate had a 58% lower risk of eclampsia (95% CI 40-71) than those allocated placebo (40, 0.8%, vs 96, 1.9%; 11 fewer women with eclampsia per 1000 women). Maternal mortality was also lower among women allocated magnesium sulphate (relative risk 0.55, 0.26-1.14).
